• 최종편집 2024-03-29(금)

English[영문판]
Home >  English[영문판]

실시간뉴스
  • Evonik Korea establishes strategic partnership with CARIMA and BREEZM
    Evonik Korea establishes strategic partnership with CARIMA and BREEZM     Evonik Korea, CARIMA and BREEZM signed a Memorandum of Understanding(MoU) for strategic cooperation in Seoul, Korea. Mr. Thomas Choi, Korea Cluster Head, Mr. Kwangmin Kim, Vice President of CARIMA and Mr. Wooseok Sung, President of BREEZM, signed the relevant documents on behalf of the three parties. According to MoU, Evonik Korea will deepen cooperation and continue developing proper photopolymer resins. Furthermore, it will be a momentum to speed up the development of DLP 3D printing technology including photopolymer resins.    
    • English[영문판]
    2023-05-10
  • 산업계 및 NGO 단체, 동물대체시험 협력조직(ICCS) 설립
    한국무역협회     전 세계 35 개 이상의 화장품 제조업체, 산업 단체 및 동물보호단체는 동물대체시험(비동물시험) 촉진을 목적으로 하는 ‘화장품안전국제협력(International Collaboration on Cosmetics Safety, ICCS)‘ 조직을 설립했다. 뉴욕에 사무소를 두고 있는 글로벌이니셔티브 ICCS 는 화장품, 퍼스널케어 및 그 성분에 대한 동물대체 안전성평가 채택을 위해 자금을 지원하며, 동물대체시험 가속화를 위한 규제기관에 대한 압력이 증가하는 가운데 설립됐다. 2월 8일 발표된 ICCS 의 목표는 아래와 같다. - 비동물시험 안전성 평가방법 평가 및 개발 - 평가결과 규제기관과 공유 - 비동물시험의 채택 가속화를 위한 산업계 교육 및 훈련 제공 유럽화장품협회(Cosmetics Europe)에 따르면, 이미 많은 프로젝트가 ICCS 를 통해 진행되고 있으며, 최근 미국은 개인위생용품에 대한 대부분의 동물실험을 단계적으로 중단하는 의회 권고 및 화장품 법안이 채택된 바 있다. 캐나다 정부 또한 신규물질에 대한 동물실험을 줄이기 위한 규제 개정을 검토하고 있으며, 캐나다화장품협회(Cosmetics Alliance Canada, CAC)는 2023년 동물대체세계대회(Animal Alternatives World Congress)를 개최할 예정이다. [출처: Chemical Watch]
    • English[영문판]
    • Animal Right
    2023-02-19
  • 하천 내 반려동물 운동·휴식 편의시설 설치 하천법 일부개정법률안 대표발의
        더불어민주당 김회재 의원(전남 여수시을)은 13일 하천 내 반려동물 편의시설을 설치할 수 있도록 하는 내용의 '하천법 일부개정법률안'을 대표 발의했다. 현행법 상 하천구역에서 가축을 방목·사육하는 행위는 금지되어 있다. 그러나 반려동물 가구가 늘어남에 따라 반려동물과 함께 하천을 이용하는 사례가 많아, 이들을 위한 별도의 휴식 등 편의시설이 필요하다는 지적이다. 이에 김 의원은 개정안을 통해 하천구역 내 반려동물 운동·휴식시설을 설치할 수 있도록 규제 조항을 일부 완화했다. 또한 이용 급증에 따라 발생할 환경 오염을 예방하기 위해 오염 실태 주기적 검사, 오염 우려지역 조치 명령 등도 개정안에 포함했다. 국무조정실은 올해 2월 규제개혁신문고에 접수된 국민 건의 중 하천 내 소규모 반려동물 놀이터 등 설치를 대표 사례로 선정해, 2022년까지 법 개정을 추진하겠다 밝힌 바 있다. 김회재 의원은 “반려동물 천만 시대에 많은 시민이 반려동물과 함께 생활하고 있다. 시민과 함께하는 반려동물도 불편함이 없도록 규제를 완화할 필요가 있다”고 지적했다.
    • English[영문판]
    • Animal Right
    2022-05-13
  • '개 식용 문제 논의를 위한 위원회' 운영 연장
               '개 식용 문제 논의를 위한 위원회'는 2021년 12월 9일 출범 후 4월 현재까지 개 식용 문제 해결을 위한 논의를 진행해 왔다.   그동안 활발한 논의를 통하여 개 식용 종식이 시대적 흐름이라는 인식에 공감대를 이루는 성과가 있었으나 아직 합의에는 이르지 못해, 추가적인 논의를 위해 위원회 운영을 2개월 연장하기로 결정하였다.   위원회는 운영 초기부터 개 식용 문제에 대해 이해관계자 등 참여자들 간에 입장 차이가 커서 상호 이해의 폭을 넓히는 것에 중점을 두어 운영하였다.   이에 따라 개 식용 문제 논의에 활용하기 위해 식용 목적 개 사육 현황 등을 조사했으며, 이는 식용 목적 개 관련 통계 자료가 없었던 상황에서 정부가 처음으로 조사했다는 의미가 있다. 또한 개 식용 관련 국민의 인식을 알아보기 위한 설문조사를 실시하였다.   한편 갈등관리 전문기관을 통해 참여 위원과 관련 업계 종사자 등에 대한 심층면접을 실시하여 종식시기, 지원방안 등 그들의 관심 사항과 대립되는 입장을 정확히 진단하여 갈등을 해결하기 위해 노력하였다.     아울러 대만의 개 식용 종식 관련 현지 전문가와 국제 화상회의를 통해 ‘대만의 종식 사례’를 파악하는 등 공감의 폭을 넓혔으며, 이외에도 ‘개 식용 관련 위생적 문제점’, ‘현행법 체계’ 등에 대한 전문가 발표와 논의를 통해 개 식용과 관련한 현 상황을 진단하고 이해를 도모하였다.   참고로 정부는 2021년 11월 25일 국무총리 주재로 ‘국정현안점검조정회의’를 개최하여 '개 식용 문제에 대한 사회적 논의 추진 방향'을 논의하였으며, 그 결과 사회적 논의기구를 관련 동물보호단체, 육견업계, 전문가, 정부 인사 등 21명으로 구성하여 개 식용 문제를 논의하기로 한 바 있다.   정광호 위원장은 "위원회 운영의 기본 원칙인 합의 정신을 실현하기 위해 육견업계와 동물보호단체 등의 입장을 발표할 수 있는 기회를 부여하는 등 충분한 시간을 가지고 논의하는 방식으로 위원회를 운영했으며, 개 식용 종식이 시대적 흐름이라는 인식을 같이하는 성과를 거두었다”라고 강조하면서, "앞으로 그동안 쌓은 위원 간 신뢰와 공감대를 바탕으로 대타협을 도출하기 위해 최선을 다하겠다”라고 밝혔다.
    • English[영문판]
    • Animal Right
    2022-05-06
  • Safety is SKC Evonik Peroxide Korea’s best value.
    Safety is SKC Evonik Peroxide Korea’s best value.     SKC Evonik Peroxide Korea Co., Ltd. (SEPK) in Ulsan Petrochemical Industrial Complex, has achieved 15 times of accident-free goal.  SEPK, maintaining a stable growth in the domestic peroxide industry, declared the start of accident-free goal on December 12, 2003. With the declaration, it has emphasized that safety is the highest value that pursues the sustainable growth of the company and the happiness within the employee’s family. Then by encouraging voluntary participation and activeness of every employee, 15 times of accident-free goal have been achieved on February 19, 2022.   During that period, SEPK has successfully implemented large and various projects such as the triple increase in production capacity with stable operation. SEPK as the sole supplier of the peroxide applicable to HPPO (Hydrogen Peroxide Propylene Oxide) in the country, produces and supplies diverse products including the electronic grade peroxide home and abroad.    Thomas Choi, Representative Director of SEPK, said that Evonik Industries AG, the parent company of SEPK, is operating the system of Evonik Safety Award to ensure accident-free and SEPK won Evonik Emerald Safety Award zero loss time injuries for 25 years) for being accident-free until 2018 after the start-up of the plant in 1993.    Thus, the accident-free goal along with such company safety system has been instrumental in embedding a safety culture in employees and the way of daily life. Choi also added that employees have a strong will to reverify that they are the leader in the peroxide industry based on strong safety by winning Evonik Ruby Safety Award (zero loss time injuries for 30 years) in the near term in December 2023 and achieving 20 times of accident-free goal in November 2028.
    • English[영문판]
    2022-04-12
  • CEO Interview , Mr. Lee Seung Soo (CEO / Infineon technologies Korea)
    CEO Interview , Mr. Lee Seung Soo  (CEO / Infineon technologies Korea)   Interviewer : Alicia Song ( GEBS , Reporter) Interviewee : Mr. Lee Seung Soo  (CEO / Infineon technologies Korea) Reporter   (Hello Everyone, my name is Alicia Song and I am a reporter for GEBS, a foreign company news station in Korea.  I am also the Director of Public Relations at the KOFA. Today, I am honored to be joined with Mr.Lee Seung-Soo, the country manager of the Korean branch of Infineon Technologies)  (Hello Mr. Lee, first of all, thank you very much for accepting this interview.  I know that Infineon Technologies headquarters is based in Germany and Infineon Technologies Korea’s branch is located in Samseong-dong, Gannamgu, Seoul).  Would you please share with us an introduction about Infineon Technologies?) Mr. Lee Seung Soo  :  In the 2020 fiscal year (ending 30 September), Infineon reported revenue of more than €8.5 billion with a workforce of some 46,700 people worldwide. Following the acquisition of the US company Cypress Semiconductor Corporation in April 2020, Infineon is now a global top 10 semiconductor company. We play a key role in shaping a better future – with microelectronics that link the real and the digital world. Our semiconductors enable efficient energy management, smart mobility, as well as secure, seamless communications in an increasingly connected world. Infineon Technologies Korea is located in Samseong-dong, Gangnam and working around 240 employees. Also we set up the sales office in Daegu to provide qualified support for customers in South area. Major customers are Hyundai Motor group, Samsung Electronics and LG Electronics and Infineon Korea have ranked No.1 in Automotive semiconductor area.  Reporter   (Thank you for the introduction. Would you please describe what the organizational culture (OD & Culture) and ideal Talent Style of Infineon Technologies Korea is?) Mr. Lee Seung Soo  :   Infineon Korea respects Korean culture based on IFX head quarter’s structure. All employees are responsible for own work and we place a high value on exchanging necessary feedback each other. There’s a communication format called Leadership dialogue that not only the manager give feedback to the staffs, but the staffs also give feedback to their manager.  Infineon Korea is working on a campaign to call nickname instead of Korean title. We will continue this campaign to make more respectful and equal organizational culture.  Reporter   (Would you please outline the compensation & benefits (C&B) and HR (HRM) system of Infineon Technologies Korea?) Mr. Lee Seung Soo: Infineon Korea provides ‘Flexible spending account’ what employees can use this one like credit card anywhere, anytime. And we are constantly trying to offer the necessary program for employee’s wellness.  Infineon Korea operate global HR system stably. Managers have a performance evaluation with each employee frequently and we managing not only evaluation, but also various training program for employee’s development. Reporter   (How would you describe the labor-management culture of Infineon Technologies Korea?) Mr. Lee Seung Soo:  We have the labor-management council meeting quarterly. Council members from workers are collecting feedbacks regarding all of company life and they put it on the table in labor-management council meeting. All council members discuss new feedbacks and notice the conclusion quarterly.  Reporter   (Would you be able to inform us of any job position currently available at Infineon Technologies Korea or a position that is scheduled to be available in the second half of this year?) Mr. Lee Seung Soo:  Infineon Korea recruits experienced employee time to time. Please refer to the Infineon website for the details of recruiting. www.infineon.kr Reporter  -  (As a successful leader and CEO, it would be great if you could share some advice for working mothers who dream of becoming CEOs of foreign companies in the future?) Mr. Lee Seung Soo:  Most working mothers should take care of both their family and work. They are used to doing two things same time and they know how to use their time efficiently. To finish the work in time, concentration and sensitivity are required. As such, working mothers have many strengths.  I think it’s important to experience various positions in one field if you have a goal to become a CEO. For example, If you’re working as engineer you can try sales position, if you’re working as sales you can try marketing position. Make your unique career focusing on the position what enable to catch the big flow of company’s moving forward. I look forward to meeting many woman CEOs soon. Reporter -  (The world economy has been stunned since the Pandemic.  Would you please highlight some of the real difficulties that currently surround your company industry as well as the future outlook of the industry?) Mr. Lee Seung Soo:  As many people know already Automotive semiconductor supply issue is very serious now days. Semiconductors account for 18% of the total cost of automotive electronics in 2000 but it’s 40% in 2020. The demand has increased significantly but only few foundry companies produce automotive semiconductor because it’s not profitable. It’s expected to continue overeating of automotive semiconductors for a while due to great interest of autonomous driving, electric vehicles and COVID pandemic. To counteract this problem, Infineon is doing the best to find good solutions for our customers. Reporter -  (Lastly, as a mentor who contributes so much to his community, please share with us any wisdom you may have for young job seekers) Mr. Lee Seung Soo:  We are living in an era of rapid change and COVID pandemic has made it harder to get a job. But the economic is slowly recovering and I believe there are opportunities even though it’s a difficult situation. It’s late if you start preparing when the good opportunity happened. You should decide the direction you want to go and make the qualifications and experience to match the job you want. If you decide a job you want to do, I’d like to recommend that you get information about the company you want to work as much as you can. It would be helpful that find the company’s management direction, changes in the industry and company’s outlook. Many companies want you if If you can clearly show your potential and your goals to contribute within the company.
    • English[영문판]
    2022-04-11

실시간 English[영문판] 기사

  • [단독 외신] Louis Vuitton’s LVMH beefs up legal team in fight over Tiffany merger
    [단독 외신] Louis Vuitton’s LVMH beefs up legal team in fight over Tiffany merger Shutterstock The company behind Louis Vuitton and Christian Dior is building its legal team as it fights claims that its trying to wiggle out of a $16 billion merger with Tiffany. LVMH has hired famed French lawyer Jean-Michel Darrois to help advise it on the battle, which threatens to raise the curtain on French governmental proceedings, two sources close to the situation said. Darrois, a commander of the French Legion of Honor, has been a public supporter of French President Emmanuel Macron. In 1999, he defended French Prime Minister Laurent Fabius in a suit that obtained a dismissal and is now a counselor to French CEOs and other wealthy people. The battle between the two retailers kicked off earlier this month when LVMH said it wouldn’t be able to complete its $16.2 billion merger of the New York jeweler featured in the 1961 flick “Breakfast at Tiffany’s,” by the Nov. 24 deadline. In a statement, LVMH said the French government had instructed it in a letter to wait until Jan. 6 of next year to close the deal in response to the US’s threat to impose tariffs on French goods. Tiffany has sued LVMH in Delaware to force it to meet the Nov. 24 deadline because once the merger agreement expires, LVMH can seek to lower the price or walk away. And as The Post has previously reported, people close to Tiffany have been raising questions about whether LVMH CEO Bernard Arnault, or those close to him, pressured French government officials for help in obtaining the letter as a pretext to delay the merger. “LVMH’s shifting explanations indicate bad faith in its dealings with Tiffany and are nothing more than distractions meant to hide its efforts to run out the clock and avoid fulfilling its obligations under the merger agreement,” Tiffany said in a statement on Wednesday. The company has blasted LVMH’s government request as “a non-binding advisory letter” and is expected to explore whether France can even order a company to stop a merger without first going through the European Union. Darrois is expected to help LVMH — and Arnault, the richest man in Europe — manage this aspect of the case and not the Delaware court lawsuit, sources said. ”He’s viewed in Paris as the ultimate consigliere,” the source said. LVMH, which declined to comment, has said it is doing all it can to close the deal.
    • English[영문판]
    2020-09-17
  • [단독외신] Bill Gates says Pfizer has best shot at early COVID-19 vaccine
    [단독외신] Bill Gates says Pfizer has best shot at early COVID-19 vaccine Bill Gates says Pfizer has the best chance of seeking emergency approval for a coronavirus vaccine by next month even though he thinks such an aggressive timeline is unlikely. “The only vaccine that if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer,” the billionaire tech tycoon-turned-philanthropist told CNBC in an interview published Tuesday. Pfizer’s vaccine is one of three currently going through so-called Phase 3 clinical trials in the US, crucial late-stage studies aimed at proving whether the inoculations are safe and effective. CEO Albert Bourla said this week that the New York-based drugmaker will likely know by the end of next monthwhether its experimental COVID-19 shot actually works. Gates — a Microsoft co-founder who is the world’s second-richest person with a net worth of $122.9 billion — noted that Pfizer’s shot produced “good antibody levels” in the first two stages of clinical testing. But he nevertheless doubts that any candidate will try to have a vaccine approved in the US by the end of October, according to CNBC. “I do think once you get into, say, December or January, the chances are that at least two or three will (seek approval) — if the effectiveness is there,” Gates told the network. Gates also noted that Pfizer and eight other drugmakers have pledged not to seek emergency authorization or approval for their vaccines until they’re proven safe and effective. The companies made the joint pledge last week amid reports that the Trump administration would try to fast-track the approval process. “The good news is that the leading vaccine companies today said that they won’t apply even for the emergency use license until they have a proof of efficacy,” Gates said in the CNBC interview. “We also have to go through all the safety steps so that people feel like they want to participate in taking this vaccine.” Pfizer was one of 15 life sciences companies that partnered with the Bill & Melinda Gates Foundation in March to speed up the development and delivery of COVID-19 vaccines, diagnostics and treatments. The foundation’s Strategic Investment Fund has also invested in Pfizer and other pharmaceutical firms involved in the vaccine race, including Merck, Sanofi and Pfizer partner BioNTech, according to its website.
    • English[영문판]
    2020-09-16
  • Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia
    Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrated BI 425809 has met its primary endpoint. The data showed improvement in cognition in stable adult patients with schizophrenia.[1] Central to many everyday tasks, impairment of cognitive function still constitutes a major burden for patients, and no pharmacological treatments are currently approved for cognitive impairment associated with schizophrenia (CIAS). These results presented at the 33rd European College of Neuropsychopharmacology (ECNP) Congress will advance the understanding of how deficits in transmission of signals between nerve cells may contribute to diminishing cognition in people living with schizophrenia.[2] The Gly-T1 inhibitor, BI 425809, forms a key component of Boehringer Ingelheim’s Central Nervous System (CNS) research program. The latest trial results, along with an ongoing combination Phase II study of BI 425809 and adjunctive computerized cognitive training, will help determine the direction for BI 425809 in further schizophrenia research.[3,4] Prof. W. Wolfgang Fleischhacker, Medical University Innsbruck, Austria: “The outcome of this trial is an important step forward in our understanding of cognition in schizophrenia. Cognitive impairment causes significant challenges for people in their everyday functioning. Patients with schizophrenia struggle with remembering things like birthdays, learning new tasks, concentrating, or making decisions that affect their everyday life. Advancing our understanding of how we might improve these symptoms in schizophrenia is significant for the research community and the patients and families living with this condition.” The Phase II results of BI 425809 in cognitive impairment associated with schizophrenia are being further evaluated to assess how they will support the continued research and development for the treatment of schizophrenia. “The trial results for our investigational compound BI 425809 in schizophrenia are encouraging. This is a positive advancement in our mechanistic knowledge of how excitatory neurotransmissions affect aspects of mental illness, aligning with our systematic neurobiological approach to CNS research,” adds Dr Vikas Mohan Sharma, M.D., head of medicine CNS, Retinopathies & Emerging Areas, Boehringer Ingelheim. “We recognize this is important news for people affected by schizophrenia. We are making progress in developing treatments which will not only reveal important advances in our understanding of schizophrenia but also potentially other neuropsychiatric diseases.” Cognition is a fundamental aspect of everyday life, including problem solving, memory and attention. When affected, people living with poor cognition can have a reduced mental ability to process information, remember straightforward things or perceive other people’s emotions and expressions. These functions are common to many forms of mental disorders such as schizophrenia, Alzheimer’s disease and depression. Finding solutions for cognitive impairment is a key area of Boehringer Ingelheim CNS research.
    • English[영문판]
    2020-09-16
  • Corona Chuseok 'Kim Young-ran Act' announced an upward revision of the upper limit of agricultural and fisheries products futures from 100,000 won to 200,000 won.
    Corona Chuseok 'Kim Young-ran Act' announced an upward revision of the upper limit of agricultural and fisheries products futures from 100,000 won to 200,000 won. A major Korean holiday, Chuseok (also known as Korean Thanksgiving), is coming at the end of the month (September 30 – October 2), and for this holiday season only, the Korean government has passed a temporary increase to the gifts threshold under the Anti-Graft Act. The temporary increase applies only to gifts comprised of agricultural/fisheries products (described below), and the limit will increase from KRW 100,000 (approx. US$85) to KRW 200,000 (approx. US$170). The increased limit is applicable from September 10 to October 4, 2020. As you may be aware, the Anti-Graft Act generally prohibits giving (1) anything of value to Public Officials (including officers and employees of government entities, state-owned enterprises, public entities, public or private media companies, public or private schools) when related to the Public Official’s duties, and (2) any benefit exceeding KRW 1 million per instance or KRW 3 million in aggregate per fiscal year when not related to the Public Official’s duties. The Anti-Graft Act provides several exceptions, however, including for meals and gifts provided to facilitate the relationship or as a matter of courtesy (but not when there is a “directly pending matter”). The meals limit is KRW 30,000 and the gifts limit is KRW 50,000, with a higher limit of KRW 100,000 for gifts comprised of at least 50% agricultural or fisheries products. “Agricultural or fisheries products” are defined by statute and include, for example, boxes of fruit, meat, or fish, which are common holiday gifts; however, they do not include, for example, salt or certain processed foods. To address the difficulties within the agricultural and fisheries industries in light of the COVID-19 pandemic, the Anti-Corruption and Civil Rights Commission (ACRC; government entity overseeing the Anti-Graft Act) proposed a temporary increase to the limit for gifts comprised of agricultural and fisheries products, from KRW 100,000 to KRW 200,000. It passed the State Council’s review on September 10, 2020, and will apply until October 4, 2020.
    • English[영문판]
    2020-09-11
비밀번호 :